We chat about optimizing biotech workflows and achieving milestones efficiently. Bogdan shared insights into how companies can better manage research and development processes, reducing operational inefficiencies and saving time, resources, and money.

In this episode, I discuss actionable tips from our recent book club read, 'Captivate,' on how to enhance your charisma for job interviews and networking. I'll share key themes and personal strategies for making a strong first impression, even if you're not naturally charismatic. Learn about the importance of setting up your environment, using body language effectively, and engaging others with genuine interest.

The Biosecure Act, which limits contracts with WuXi AppTec, WuXi Biologics and three other companies, still needs Senate support to advance.

Tuesday’s round brings Bain Capital Life Sciences’ fundraising total to around $6.7 billion since its founding in 2016. Many of its portfolio companies have resulted in high-value exits recently, including Cerevel Therapeutics, Aiolos Bio and Jnana Therapeutics.

The startup believes T cell engagers, rather than cell therapies, will prove the “right horse to bet on” in the race to develop new inflammatory disease treatments, its CEO said.

Zenas BioPharma Inc. and Bicara Therapeutics Inc. on Friday both set estimated price ranges in their initial public offerings in a sign that the traditional summer lull in deals is coming to an end.